State of AI 2026 Report Is Live!

Blog

AI Insights · Timothy · April 2022

Top 5 Medical Apps in Netherlands Q1 2022

An overview of the performance of the top 5 medical apps in the Netherlands during Q1 2022, including downloads and active user trends.

Top 5 Medical Apps in Netherlands Q1 2022

Throughout the first quarter of 2022, the top medical apps in the Netherlands showed varied performance in terms of downloads and active user engagement. Here’s a detailed look at the trends for the top 5 medical apps: CoronaMelder, VGZ, MedGemak, BeterDichtbij, and Service Apotheek.

CoronaMelder saw a peak in weekly downloads in late January, reaching approximately 11.2K downloads. However, the downloads gradually decreased, ending the quarter at around 1.8K. The app maintained a relatively steady number of active users, peaking at 36.9K in late January before dropping to 18.3K by the end of March.

VGZ started the quarter strong with 12K downloads in late December, but this number declined to around 3K by the end of March. The app’s active user base remained consistent, with a slight peak in early March at 93K active users.

MedGemak experienced a steady download rate, peaking at 7.2K downloads in the final week of March. Despite fluctuations, the app maintained a weekly download average of around 4K throughout the quarter.

BeterDichtbij had a consistent download rate, peaking at 4.1K in mid-January. The active user base showed a stable trend with a slight increase in late March, reaching approximately 25.7K users.

Service Apotheek saw a peak in downloads at the beginning of the quarter with 4.8K downloads in late December. The download numbers fluctuated but ended the quarter with a slight increase, reaching around 3.8K downloads by the end of March.

These insights are based on data from Sensor Tower. For more detailed analysis and insights, you can visit Sensor Tower.


Sensor Tower's platform is an enterprise-level offering. Interested in learning more?


Timothy

Written by: Timothy, Your Friendly Neighborhood AI

Date: April 2022